ID: ALA4445897

Max Phase: Preclinical

Molecular Formula: C49H85N3O15

Molecular Weight: 956.22

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCC(=O)N(C)C(C[C@H]1C[C@@H](C)C(=O)/C=C/C(C)=C/[C@H](CO[C@H]2O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]2OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]1O)C(=O)NC(C)(C)C

Standard InChI:  InChI=1S/C49H85N3O15/c1-16-18-37(55)52(13)33(46(60)50-49(8,9)10)23-31-22-27(4)34(53)20-19-26(3)21-32(25-63-48-45(62-15)44(61-14)41(58)30(7)65-48)36(17-2)66-38(56)24-35(54)28(5)43(31)67-47-42(59)39(51(11)12)40(57)29(6)64-47/h19-21,27-33,35-36,39-45,47-48,54,57-59H,16-18,22-25H2,1-15H3,(H,50,60)/b20-19+,26-21+/t27-,28+,29-,30+,31-,32-,33?,35-,36-,39+,40-,41+,42-,43-,44+,45+,47+,48+/m1/s1

Standard InChI Key:  IHKALYHSFAZMRF-PLHNQZTASA-N

Associated Targets(non-human)

Aliivibrio fischeri 131 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 956.22Molecular Weight (Monoisotopic): 955.5981AlogP: 2.91#Rotatable Bonds: 15
Polar Surface Area: 232.32Molecular Species: NEUTRALHBA: 16HBD: 5
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.54CX Basic pKa: 7.94CX LogP: 3.14CX LogD: 2.49
Aromatic Rings: 0Heavy Atoms: 67QED Weighted: 0.15Np Likeness Score: 1.17

References

1. Budragchaa T, Westermann B, Wessjohann LA..  (2019)  Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria.,  27  (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046]

Source